The problem of small
things
D. Brinkerhoff & D. Hamilton
NANOTECHNOLOGY,
according to its fans, will jumpstart a new industrial revolution with
molecular-sized structures as complex as the human cell and 100 times
stronger than steel.
The new technology
transforms everyday products and the way they are made by manipulating
atoms so that materials can be shrunk, strengthened and lightened all at
once.
To date only modest
nanotech-based products—such as stain-resistant fabrics and fresh food
packaging — have entered the market, but some scientists predict
nanotechnology will eventually be the only game in town.
"It will be a
ubiquitous technology," says George Stephanopoulos, professor of
chemical engineering at the Massachusetts Institute of Technology (MIT).
He echoes other nanotech supporters who say industrial countries are
already sliding towards its use in every aspect of manufacturing.
But with such a huge gap
between what is and what might be, it remains a difficult realm for
investors, who cannot yet be confident that the global market will reach
$1 trillion by 2015, as the US government predicts.
Theory says it is all
possible. A nano is a measurement of a billionth of a metre or about the
size of 10 hydrogen atoms. That translates into 1/80,000 the diameter of
a human hair.
Aided by recent advances
in microscopes, scientists can now place single atoms where they want
for the first time. The potential applications are numerous, with
microscopic computers, cancer-killing antennae and non-polluting car
engines on the distant horizon.
Impediments
When it’s all going to
happen, though, is another matter. According to most scientific
accounts, the nanotech future may be 10 to 20 years off. Major hurdles
need to be jumped.
First, there is a lack of
economic mass production. Some of the more complicated devices would
require exact placement of billions of atoms. "It may take the
lifetime of the universe to complete the construction of (such a)
device," George Barbastathis, assistant professor in mechanical
engineering at MIT tells Reuters.
Another challenge is
bridging the nanoscale and macroscopic, he says. In other words, the
smallness of a nano device is useless when it must be attached to large
wires. It’s unclear how scientists will overcome these problems.
"There’s too much
hype about making things small without too much reasoning," says
Francesco Stellacci, MIT assistant professor of materials science and
engineering.
And fears derived from
science fiction threaten to derail nanotechnology even as it emerges, in
much the same way that popular anxiety over "superweeds" and
"frankenfoods" have hobbled biotechnology in agriculture and
fear of "designer babies" has set back stem-cell research.
Environmental groups have called for a moratorium on nanotech research
until any risks to society, the environment or human health have been
established. That looks unlikely, given the political support for
cutting-edge technologies across the world. The US Congress last year
increased funding for nanotechnology research to $3.7 billion over four
years. The European Union and Japan are also investing heavily in
research into the new technology.
Huge potential
Major corporations do not
want to be left behind either. Lured by a market with billions of
dollars in potential profits, giants like GE, Intel, Motorola and IBM
are already heavily involved in research.
There are also a number of
leading start-ups, like Carbon Nanotechnologies (CNI) in Houston and
Frontier Carbon, a Mitsubishi Chemical joint venture. Worldwide, the two
industries with the potential to win big with nanotechnology are
electronics and biotechnology, according to MIT researchers. On the
biotech front, scientists are promoting the notion of nanoparticles made
from gold that could be triggered remotely to heat and kill individual
cancer cells. It’s that kind of project that gives nanotech the same
appeal as biotechnology had in the 1980s, when scientists and
entrepreneurs worked in tandem to fuel an industry with new advances in
genetic research. Nanotechnology holds equal promise for wealth
creation, but there isn’t a consensus among venture capitalists on how
to realise it. "Which direction is it going to work out in? That’s
the question on everyone’s mind," Gang Chen, an associate
professor of mechanical engineering at the MIT, told scientists at a
Boston nano gathering.
Venture capitalists are
finding a confusing assortment of new applications for a science that
can baffle even the most experienced investor.
Unlike biotech, where a
range of prospective products is mostly limited to those aimed at
treating various human diseases, potential nanotech-based products can
be applied to healthcare to chip making to aerospace, posing challenges
for venture capitalist specialists trained in only one area.
|